Working… Menu

Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04025502
Recruitment Status : Completed
First Posted : July 19, 2019
Last Update Posted : February 24, 2021
Alkermes, Inc.
Anavex Life Sciences Corp.
Merck Sharp & Dohme Corp.
Sage Therapeutics
H. Lundbeck A/S
Astellas Pharma Inc
Apex Innovative Sciences
Columbia University
Information provided by (Responsible Party):
ERP Biomarker Qualification Consortium

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 29, 2020
Actual Study Completion Date : January 31, 2021